Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients

Brenda F. Kurland, Vijayakrishna K. Gadi, Jennifer M. Specht, Kimberly H. Allison, Robert B. Livingston, Eve T. Rodler, Lanell M. Peterson, Erin K. Schubert, Xiaoyu Chai, David A. Mankoff, Hannah M. Linden

Research output: Contribution to journalArticle

22 Scopus citations

Fingerprint Dive into the research topics of 'Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences